485 results on '"Schueler, S."'
Search Results
102. AN INDIVIDUALIZED STRATEGY FOR THE POSTOPERATIVE TREATMENT IN CARDIAC TRANSPLANT RECIPIENTS OVER 60 YEARS OF AGE
103. MMF
104. DIRECT ANALYSIS OF REPERFUSION INJURY MEDIATORS FOLLOWING LUNG ISCHEMIA IN AN IN VIVO MODEL
105. Environment rather than genetic background explains intraspecific variation in the protein-precipitating capacity of phenolic compounds in beech litter
106. EACTS/ESCVS best practice guidelines for reporting treatment results in the thoracic aorta
107. 16 - Cell culture systems for kidney research
108. (1324) - Ventricular Arrhythmias in Long Term LVAD Patients - Life Threatening Situation or Nothing to Worry About?
109. (1305) - Heparin Induced Thrombocytopenia Type II in Mechanical Circulatory Support Recipients
110. (526) - High-Risk and Low-Risk Donor/Recipient Characteristics and 90-Day Transplant Outcomes in LVAD versus Standard Recipients
111. (130) - Durable LeftVentricular Assist Device Therapy to Reduce Transpulmonary Gradient in Adult Congenital Heart Disease to Facilitate Heart Transplant
112. (45) - Epidemiology of Bloodstream Infections in MCSD Recipients in the IMACS Registry
113. (46) - The Epidemiology of Infection in MCS from the IMACS Database: January 2013 to December 2015
114. Preexisting cognitive impairment in intracerebral hemorrhage.
115. 022 * NOVEL MINIMALLY INVASIVE DECOMMISSIONING OF HEARTWARE LEFT VENTRICULAR ASSIST DEVICE FOLLOWING MYOCARDIAL RECOVERY
116. Four-year outcomes with third-generation centrifugal left ventricular assist devices in an era of restricted transplantation
117. A New Outpatient Surveillance Program Improves Home Based Care in Long Term LVAD Recipients
118. Extended Bridge To Transplant: 4 Years Outcomes With 3rd Generation LVADs in an Era of Restricted Transplantation
119. Mechanical Circulatory Support for Failing Systemic Right Ventricle Using Left Ventricular Assist Device - An Option To Decide and Bridge?
120. Development of De-Novo Aortic Valve Incompetence in Patients With the Continuous Flow Heartware® Ventricular Assist Device
121. Long Term Analysis of RV Function in Patients After Continuous Flow Heartware® LVAD Implantation Without the Need for Peri-Operative Mechanical RV Support - Honeymoon Period or Sustainable Success?
122. Socio-Economic Classification Is a Predicator of Long Term Survival in Patients With Left Ventricualr Assist Device
123. Long-distance gene flow and adaptation of forest trees to rapid climate change
124. (1108) - Agreeing to Disagree: A Comparison of Antiplatelet and Anticoagulant Management Strategies at US versus International HVAD Implanting Centers
125. (963) - A Review of Warfarin Management in Patients Supported with a Heartware HVAD Using Home INR Testing
126. (199) - Impact of Aortic Valve Closure on Adverse Events and Outcomes with the HeartWare HVAD
127. A New Universal Wireless Transcutaneous Energy Transfer (TET) System for Implantable LVADs – Preliminary In Vitro and In Vivo Results
128. Improving Outcomes in Lung Transplantation for Cystic Fibrosis – A Unified Approach
129. Driveline Exit Site in Long Term LVAD’s – Patient Choice or Surgeon’s Decision
130. Editorial Comment: Ventricular assist devices for advanced heart failure: evidence that cannot be ignored
131. Three-year follow-up after port-access mitral valve surgery.
132. Divergent pattern of nuclear genetic diversity across the range of the Afromontane Prunus africana mirrors variable climate of African highlands
133. A complication of trans-septal puncture during VT ablation: clinical application of transoesophageal echocardiography in interventional procedures
134. 777 Left Ventricular Assist Device Implantation Significantly Improves Everyday Physical Activity and Quality of Life in Patients with Chronic Heart Failure
135. 540 Optimized RV Function Prior to LVAD Implantation – Honeymoon Period or Sustainable Success?
136. 573 Improved Surgical Technique of Left Ventricular Assist Device Drive Line Placement
137. 805 LVAD Patient Pack; a Potential Reservoir for Pathogenic Organisms
138. 27 Improving Patient Satisfaction in Wound Care of Left Ventricular Assist Device Exit Sites
139. Lesen und Interpretieren von Metaanalysen diagnostischer Genauigkeitsstudien
140. 82 Management of advanced heart failure in the UK: trends in heart transplantation and mechanical circulatory support
141. 83 Clinical and haemodynamic status beyond 3 months of mechanical support with the heartware ventricular assist device
142. The decline in heart transplantation in the UK
143. 625 Platelet Mapping Thromboelastography for Individualized Antiplatelet Treatment after Implantation of the HeartWare Ventricular Assist Device
144. 276 Demonstration of Hypercoagulability after Implantation of the HeartWare Ventricular Assist Device by Using Thromboelastography
145. 112 Right Ventricular Optimisation in Patients with Biventricular Failure Receiving a Left Ventricular Assist Device – A Safe Strategy To Avoid Mechanical RV Support
146. (109) - Effective Transcutaneous Energy Transfer Allows for More Than 6 Hours of Freedom From External Gear - The Future Is Here
147. (84) - Long Term Measurements of Aortic Root and Left Ventricular Dimensions in Patients on HeartWare® Ventricular Assist Device - An Explanation for the Development of Aortic Incompetence in Chronic LVAD Support?
148. (2) - Long Term Support of Patients Receiving an LVAD for Advanced Heart Failure: A Subgroup Analysis of the Registry to Evaluate the HeartWare® Left Ventricular Assist System (The REVOLVE Registry)
149. P036 Effects of estriol on growth, gene expression and ERE activation in human breast cancer cell lines
150. Phylogeography of the Afromontane Prunus africana reveals a former migration corridor between East and West African highlands
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.